REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/21/2025
Back to search
Official data from USPTO
GLUCAGEN HYPOKIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLUCAGEN HYPOKIT
ST13
US500000078542647Class
5
Filing
78542647
Registration
3175128
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
11/23/2025
Trademark type
Word
Nice classes
5
Filing date
01/05/2005
Registration date
11/21/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2017
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/13/2005
First use in commerce
07/13/2005
Drawing code
4
Owner type
65
Owner location
DK-2880 Bagsvaerd, DK
Examiner
SUAREZ,MARIA VICTORIA
Law office
L20
Current location
TMEG LAW OFFICE 102
Holders and representatives
Holders
Novo Nordisk A/S
Representatives
Claudia A. Smith White & Case LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Glucagon preparations for the treatment of hypoglycaemic reactions
Publications
History of USPTO decisions and trademark events.
47 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/30/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/27/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/24/2018
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/27/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/27/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/27/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/26/2017
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
01/14/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/27/2016
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
12/19/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/12/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
10/04/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/21/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2013
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/14/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/14/2012
E815
TEAS SECTION 8 & 15 RECEIVED
09/11/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2011
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/19/2008
PLGL
ASSIGNED TO PARALEGAL
06/09/2008
AMD7
SEC 7 REQUEST FILED
05/06/2008
PAPER RECEIVED
05/06/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
10/17/2006
ALIE
ASSIGNED TO LIE
10/17/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/11/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/10/2006
IUAF
USE AMENDMENT FILED
09/15/2006
EISU
TEAS STATEMENT OF USE RECEIVED
09/15/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
04/18/2006
PUBO
PUBLISHED FOR OPPOSITION
01/24/2006
NPUB
NOTICE OF PUBLICATION
01/04/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/12/2005
ALIE
ASSIGNED TO LIE
12/09/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2005
GNEA
EXAMINERS AMENDMENT E-MAILED
12/07/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/07/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2005
GNRT
NON-FINAL ACTION E-MAILED
08/06/2005
CNRT
NON-FINAL ACTION WRITTEN
08/06/2005
DOCK
ASSIGNED TO EXAMINER
08/05/2005
NWAP
NEW APPLICATION ENTERED
01/16/2005
Continuous trademark protection
Get notified about every new filing that threatens GLUCAGEN HYPOKIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.